DE69301916D1 - 5-0-desosaminylerythronolid a derivate - Google Patents

5-0-desosaminylerythronolid a derivate

Info

Publication number
DE69301916D1
DE69301916D1 DE69301916T DE69301916T DE69301916D1 DE 69301916 D1 DE69301916 D1 DE 69301916D1 DE 69301916 T DE69301916 T DE 69301916T DE 69301916 T DE69301916 T DE 69301916T DE 69301916 D1 DE69301916 D1 DE 69301916D1
Authority
DE
Germany
Prior art keywords
desosaminylerythronolide
derivative
oxo
substituted
alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69301916T
Other languages
English (en)
Other versions
DE69301916T2 (de
Inventor
Toshifumi Asaka
Masato Kashimura
Yoko Misawa
Shigeo Morimoto
Katsuo Hatayama
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Taisho Pharmaceutical Co Ltd
Original Assignee
Taisho Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Taisho Pharmaceutical Co Ltd filed Critical Taisho Pharmaceutical Co Ltd
Publication of DE69301916D1 publication Critical patent/DE69301916D1/de
Application granted granted Critical
Publication of DE69301916T2 publication Critical patent/DE69301916T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Control Of High-Frequency Heating Circuits (AREA)
  • Fats And Perfumes (AREA)
  • Amplifiers (AREA)
DE69301916T 1992-04-22 1993-04-21 5-0-desosaminylerythronolid a derivate Expired - Fee Related DE69301916T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP10149292 1992-04-22
PCT/JP1993/000516 WO1993021199A1 (en) 1992-04-22 1993-04-21 5-o-desosaminylerythronolide a derivative

Publications (2)

Publication Number Publication Date
DE69301916D1 true DE69301916D1 (de) 1996-04-25
DE69301916T2 DE69301916T2 (de) 1996-08-08

Family

ID=14302174

Family Applications (2)

Application Number Title Priority Date Filing Date
DE69305987T Expired - Fee Related DE69305987T2 (de) 1992-04-22 1993-04-21 5-0-desosaminylerythronolide a derivate
DE69301916T Expired - Fee Related DE69301916T2 (de) 1992-04-22 1993-04-21 5-0-desosaminylerythronolid a derivate

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DE69305987T Expired - Fee Related DE69305987T2 (de) 1992-04-22 1993-04-21 5-0-desosaminylerythronolide a derivate

Country Status (12)

Country Link
US (2) US5591837A (de)
EP (2) EP0638585B1 (de)
KR (2) KR0166996B1 (de)
AT (2) ATE135707T1 (de)
AU (2) AU661585B2 (de)
BR (1) BR1100235A (de)
CA (2) CA2118488C (de)
DE (2) DE69305987T2 (de)
DK (2) DK0638584T3 (de)
ES (2) ES2087737T3 (de)
GR (2) GR3019787T3 (de)
WO (2) WO1993021199A1 (de)

Families Citing this family (58)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2739620B1 (fr) * 1995-10-09 1997-12-19 Roussel Uclaf Nouveaux derives de la 5-0-desosaminyl 6-o-methyl erythronolide a, leur procede de preparation et leur application a la preparation de produits biologiquement actifs
USRE38426E1 (en) * 1995-10-09 2004-02-10 Aventis Pharma S.A. 5-O-deosaminyl 6-O-methyl erythronolide A derivatives, preparation method therefor and use thereof for preparing biologically active materials
JP2000500133A (ja) * 1995-11-08 2000-01-11 アボツト・ラボラトリーズ 三環式エリスロマイシン誘導体
US6274715B1 (en) * 1995-11-08 2001-08-14 Abbott Laboratories Tricyclic erythromycin derivatives
US5747466A (en) * 1995-11-08 1998-05-05 Abbott Laboratories 3-deoxy-3-descladinose derivatives of erythromycins A and B
US5750510A (en) * 1997-04-04 1998-05-12 Abbott Laboratories 3-descladinose-2,3-anhydroerythromycin derivatives
ATE296832T1 (de) * 1996-09-04 2005-06-15 Abbott Lab 6-o-substituierte ketoliden mit antibakteriellen wirkung
UA51730C2 (uk) * 1996-09-04 2002-12-16 Ебботт Лабораторіз 6-o-заміщені кетоліди з антибактеріальною активністю, спосіб їх одержання (варіанти), фармацевтична композиція та спосіб регулювання бактеріальної інфекції у ссавців
BR9713302A (pt) 1996-11-27 2000-03-21 Taisho Pharmaceutical Co Ltd Derivado de eritromicina a, composição farmacêutica, preparação antibacteriana, processo para o tratamento de uma doença bacteriologicamente infecciosa, e, uso do derivado de eritromicina a ou um seu sal farcamaceuticamente aceitável.
FR2757168B1 (fr) * 1996-12-12 1999-06-11 Hoechst Marion Roussel Inc Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
WO1998040392A1 (fr) * 1997-03-10 1998-09-17 Taisho Pharmaceutical Co., Ltd. Derives d'erythromycine a
WO1998042720A1 (fr) * 1997-03-24 1998-10-01 Taisho Pharmaceutical Co., Ltd. Derives d'erythromycine a
AU6932098A (en) * 1997-05-09 1998-12-08 Pfizer Products Inc. Erythromycin derivatives
HUP0004809A3 (en) * 1997-05-29 2001-11-28 Abbott Lab Multicyclic erythromycin derivatives
US5922683A (en) * 1997-05-29 1999-07-13 Abbott Laboratories Multicyclic erythromycin derivatives
US5780605A (en) * 1997-09-08 1998-07-14 Abbott Laboratories 6,9-bridged erythromycin derivatives
US5780604A (en) * 1997-09-26 1998-07-14 Abbott Laboratories 11,12-cyclic phosphite or phosphate derivatives of erythromycin and related macrolides
HN1998000159A (es) * 1997-10-29 1999-02-09 Monsanto Co Derivados de 9- amino - 3 ceto eritromicina
PA8461401A1 (es) * 1997-10-29 2000-05-24 Pfizer Prod Inc Derivados de eritromicina triciclicos
CO4990960A1 (es) * 1997-10-29 2000-12-26 Abbott Lab Derivados de cetolidos 2-halo-6-o sustituidos
US6124269A (en) * 1997-10-29 2000-09-26 Abbott Laboratories 2-Halo-6-O-substituted ketolide derivatives
FR2777282B1 (fr) * 1998-04-08 2001-04-20 Hoechst Marion Roussel Inc Nouveaux derives de la 2-fluoro 3-de((2,6-dideoxy 3-c-methyl 3-0-methyl-alpha-l-ribohexopyranosyl) oxyl) 6-o-methyl 3-oxo erythromycine, leur procede de preparation et leur application a la synthese de principes actifs de medicaments
ATE243219T1 (de) * 1998-04-24 2003-07-15 Pfizer Prod Inc 9a, 11b-dehydro derivative von 9-oxime-3-keto-6-0-methylerythromycin
AU3439899A (en) * 1998-06-03 1999-12-20 Pfizer Products Inc. Tricyclic 3-keto derivatives of 6-o-methylerythromycin
FR2784682B1 (fr) 1998-10-15 2002-12-06 Hoechst Marion Roussel Inc Nouveaux derives 2-halogene de 5-0-desosaminylerythronolide a, leur procede de preparation et leur application comme medicaments
US6054435A (en) * 1999-03-19 2000-04-25 Abbott Laboratories 6-O-substituted macrolides having antibacterial activity
US6355620B1 (en) 1999-05-14 2002-03-12 Abbott Laboratories C-2 modified erythromycin derivatives
US6569836B2 (en) 1999-12-02 2003-05-27 Abbott Laboratories 6-O-alkyl-2-nor-2-substituted ketolide derivatives
US6946446B2 (en) 2000-02-24 2005-09-20 Abbott Laboratories Anti-infective agents useful against multidrug-resistant strains of bacteria
EP1146051A3 (de) * 2000-04-10 2001-10-31 Pfizer Products Inc. Erythromycin A-Derivate
US7129221B2 (en) * 2002-05-13 2006-10-31 Enanta Pharmaceuticals, Inc. 6,11-bicyclic erythromycin derivatives
US7064110B2 (en) * 2002-05-13 2006-06-20 Enanta Pharmaceuticals, Inc. 6-11 bicycle ketolide derivatives
US6841664B2 (en) 2002-07-25 2005-01-11 Enanra Pharmaceuticals, Inc. 6,11-4-carbon bridged ketolides
US7022679B2 (en) * 2002-05-13 2006-04-04 Enanta Pharmaceuticals, Inc. Processes for the preparation of 6-11 bicyclic erythromycin derivatives
US6764998B1 (en) 2003-06-18 2004-07-20 Enanta Pharmaceuticals, Inc. 6,11-4C-bicyclic 9a-azalide derivatives
US7910558B2 (en) * 2002-05-13 2011-03-22 Enanta Pharmaceuticals, Inc. Bridged macrocyclic compounds and processes for the preparation thereof
US6878691B2 (en) * 2002-05-13 2005-04-12 Enanta Pharmaceuticals, Inc. 6-11 bicyclic ketolide derivatives
US6753318B1 (en) 2002-07-25 2004-06-22 Enanta Pharmaceuticals, Inc. 6,11-4-carbon bridged erythromycin derivatives
US7273853B2 (en) * 2002-05-13 2007-09-25 Enanta Pharmaceuticals, Inc. 6-11 bicyclic ketolide derivatives
US7135573B2 (en) * 2002-05-13 2006-11-14 Enanta Pharmaceuticals, Inc. Processes for the preparation of O-(6-Pyrazol-1-yl-pyridin-3-ylmethyl)-hydroxylamine
US6645941B1 (en) 2003-03-26 2003-11-11 Enanta Pharmaceuticals, Inc. 6,11-3C-bicyclic 9a-azalide derivatives
US7276487B2 (en) * 2003-09-23 2007-10-02 Enanta Pharmaceuticals, Inc. 9a, 11-3C-bicyclic 9a-azalide derivatives
WO2005067564A2 (en) * 2004-01-07 2005-07-28 Enanta Pharmaceuticals, Inc. 6-11 bicyclic erythromycin derivatives
US7265094B2 (en) * 2004-01-09 2007-09-04 Enanta Pharmaceuticals, Inc. 9N-substituted 6-11 bicyclic erythromycin derivatives
US7163906B2 (en) * 2004-11-04 2007-01-16 Chevron Phillips Chemical Company, Llp Organochromium/metallocene combination catalysts for producing bimodal resins
US7229972B2 (en) 2004-12-07 2007-06-12 Enanta Pharmaceuticals, Inc. 3,6-Bicyclolides
US7419962B2 (en) 2004-12-07 2008-09-02 Enanta Pharmaceuticals, Inc. 3,6-bicyclolides
WO2006065743A2 (en) 2004-12-13 2006-06-22 Enanta Pharmaceuticals, Inc. Tetracylic bicyclolides
WO2006065721A2 (en) 2004-12-13 2006-06-22 Enanta Pharmaceuticals, Inc. 11, 12-lactone bicyclolides
US7384922B2 (en) * 2005-05-04 2008-06-10 Enanta Pharmaceuticals, Inc. 6-11 bridged oxime erythromycin derivatives
US8124744B2 (en) 2006-05-01 2012-02-28 Taisho Pharmaceutical Co., Ltd. Macrolide derivatives
US20070298811A1 (en) * 2006-06-21 2007-12-27 Lockheed Martin Corporation System for predicting bandwidth capacity
WO2009006403A2 (en) * 2007-06-29 2009-01-08 Georgia Tech Research Corporation Non-peptide macrocyclic histone deacetylase (hdac) inhibitors and methods of making and using thereof
US8871728B2 (en) 2007-06-29 2014-10-28 Georgia Tech Research Corporation Non-peptide macrocyclic histone deacetylese (HDAC) inhibitors and methods of making and using thereof
US20090118506A1 (en) * 2007-09-17 2009-05-07 In Jong Kim 6,11-bridged biaryl macrolides
US8354383B2 (en) * 2007-09-17 2013-01-15 Enanta Pharmaceuticals, Inc. 6,11-bridged biaryl macrolides
US8273720B2 (en) * 2007-09-17 2012-09-25 Enanta Pharmaceuticals, Inc. 6,11-bicyclolides: bridged biaryl macrolide derivatives
TW200946109A (en) * 2008-05-09 2009-11-16 Enanta Pharm Inc Anti-bacterial activity of 9-hydroxy derivatives 6, 11-bicyclolides

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5175150A (en) * 1985-08-31 1992-12-29 Kitasato, Kenkyusho Erythromycin derivative
US4742049A (en) * 1986-06-04 1988-05-03 Abbott Laboratories Semisynthetic erythromycin antibiotics
IL99995A (en) * 1990-11-21 1997-11-20 Roussel Uclaf Erythromycin derivatives, their preparation and pharmaceutical compositions containing them
EP0559896B1 (de) * 1990-11-28 1997-08-27 Taisho Pharmaceutical Co. Ltd 6-0-methylerythromycin a-derivat
US5523399A (en) * 1991-12-27 1996-06-04 Taisho Pharmaceutical Co., Ltd. 5-O-desosaminylerythronolide derivatives

Also Published As

Publication number Publication date
ATE145212T1 (de) 1996-11-15
DK0638585T3 (da) 1996-12-02
US5591837A (en) 1997-01-07
EP0638585B1 (de) 1996-11-13
EP0638584A4 (de) 1994-12-23
DK0638584T3 (da) 1996-04-15
KR950700920A (ko) 1995-02-20
US5631355A (en) 1997-05-20
CA2118488C (en) 2002-11-05
KR100244729B1 (ko) 2000-02-15
EP0638584A1 (de) 1995-02-15
CA2118489A1 (en) 1993-10-23
AU4022393A (en) 1993-11-18
EP0638584B1 (de) 1996-03-20
EP0638585A1 (de) 1995-02-15
DE69305987D1 (de) 1996-12-19
KR0166996B1 (ko) 1999-01-15
WO1993021199A1 (en) 1993-10-28
WO1993021200A1 (fr) 1993-10-28
AU4022293A (en) 1993-11-18
CA2118488A1 (en) 1993-10-23
KR950700921A (ko) 1995-02-20
GR3021992T3 (en) 1997-03-31
DE69305987T2 (de) 1997-03-06
GR3019787T3 (en) 1996-07-31
EP0638585A4 (de) 1995-04-19
ES2096915T3 (es) 1997-03-16
CA2118489C (en) 1999-07-13
DE69301916T2 (de) 1996-08-08
AU662420B2 (en) 1995-08-31
BR1100235A (pt) 2002-04-30
ES2087737T3 (es) 1996-07-16
ATE135707T1 (de) 1996-04-15
AU661585B2 (en) 1995-07-27

Similar Documents

Publication Publication Date Title
DE69305987D1 (de) 5-0-desosaminylerythronolide a derivate
ATE157368T1 (de) 6-0-methylerythromycin a-derivat
ATE153341T1 (de) 5-o-desosaminylerythronolid derivate
ATE271557T1 (de) Dc-89 derivat
ES2088537T3 (es) Derivados de piranil cianoguanidina.
DE69505470D1 (de) Pyrrolocarbazol
DE69423339D1 (de) Epoxycyclohexendionderivat
DK0601191T3 (da) Hidtil ukendt tetracyklisk forbindelse
ES2115816T3 (es) Derivados macrolidas de 16-eslabones y su procedimiento de preparacion.
FI883507A (fi) Naftotiazepinderivat och deras framstaellning.
ATE284402T1 (de) Pyrroloindol-derivate und zwischenprodukte zu ihrer herstellung

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee